Trials / Conditions / Fibrodysplasia Ossificans Progressiva (FOP)
Fibrodysplasia Ossificans Progressiva (FOP)
6 registered clinical trials studyying Fibrodysplasia Ossificans Progressiva (FOP) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | IL1 Inhibition in FOP NCT06724562 | University of California, San Francisco | — |
| Completed | A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossifi NCT06064656 | Regeneron Pharmaceuticals | — |
| Recruiting | To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans NCT05090891 | Incyte Corporation | Phase 2 |
| Completed | A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Parti NCT05027802 | Ipsen | Phase 3 |
| Recruiting | The Fibrodysplasia Ossificans Progressiva (FOP) Registry NCT02745158 | The International FOP Association | — |
| Temporarily Not Available | An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP) NCT07301450 | Regeneron Pharmaceuticals | — |